Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Financing to close Nov 20

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Nov 18, 2023 9:47am

182 Views

Post# 35742484

RE:RE:RE:RE:RE:RE:RE:Financing to close Nov 20

With a little luck, the next data update might bring smiles back. If the stream of PP money is still there when needed in the future, this is perhaps the best way to go. But man, they need that BTD. That in itself might not move the needle but any j/v should be much better if it is given. I keep telling myself that anyway. Less than two weeks until the next udpate.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments